Health news
The Food and Drug Administration’s (FDA) Psychopharmacologic Drugs Advisory Committee voted 3 “yes” and 9 “no” on whether the available evidence supports the conclusion that pimavanserin is effective for the treatment of hallucinations and delusions…
the virtual reality (VR) tool gameChange was found to reduce agoraphobia symptoms in people diagnosed with schizophrenia or psychotic symptoms. Results of a randomized controlled trial that assessed this tool were published in Lancet Psychiatry.…
The Food and Drug Administration (FDA) has approved Igalmi (dexmedetomidine) sublingual film for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults. Igalmi is an orally dissolving thin…
A nonsystematic review found that early-life infection, inflammation, and metabolic alterations could play a role in depression and psychosis in adulthood. These findings were published in the Harvard Review of Psychiatry. Three-quarters of all psychiatric…
The Food and Drug Administration (FDA) is expected to make a decision on the supplemental New Drug Application (sNDA) for pimavanserin for the treatment of hallucinations and delusions associated with Alzheimer disease psychosis on August…
The Food and Drug Administration (FDA) has approved the supplemental New Drug Application for Rexulti (brexpiprazole) for the treatment of schizophrenia in adolescents 13 years of age and older. Previously, the treatment was only approved…
Lybalvi® (olanzapine and samidorphan) is now available for the treatment of schizophrenia in adults and for bipolar I disorder in adults for acute treatment of manic or mixed episodes as monotherapy and as an adjunct…
The Food and Drug Administration has approved Invega Hafyera (paliperidone palmitate), an every 6-month injection, for the treatment of schizophrenia in adults. Invega Hafyera is a long-acting atypical antipsychotic that is administered as a gluteal…
© 2005-2021 Top-Meds - All rights reserved. Our website services, content, and products are for informational purposes only. Top-Meds does not provide medical advice, diagnosis, or treatment. | Medical News 2021